tiprankstipranks
Pelthos Therapeutics (PTHS)
:PTHS
US Market

Pelthos Therapeutics (PTHS) Financial Statements

71 Followers

Pelthos Therapeutics Financial Overview

Pelthos Therapeutics's market cap is currently $76.84M. The company's EPS TTM is $; its P/E ratio is -1.35; Pelthos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 16.80M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 10.52M$ 0.00$ 0.00$ 0.00$ -209.05K
Operating Income$ -32.43M$ -7.57M$ -6.86M$ -2.32M$ -839.00K
EBITDA$ -30.07M$ -7.17M$ -6.86M$ -2.32M$ 0.00
Net Income$ -43.32M$ -7.96M$ -7.38M$ -2.46M$ -595.39K
Balance Sheet
Cash & Short-Term Investments$ 18.02M$ 513.44K$ 96.39K$ 55.07K$ 0.00
Total Assets$ 130.40M$ 1.37M$ 96.39K$ 55.07K$ 0.00
Total Debt$ 34.83M$ 2.19M$ 1.27M$ 540.43K$ 1.10M
Net Debt$ 16.80M$ 1.67M$ 1.17M$ 485.36K$ 1.10M
Total Liabilities$ 91.52M$ 4.08M$ 6.54M$ 3.76M$ 3.68M
Stockholders' Equity$ 38.88M$ -2.71M$ -6.44M$ -3.71M$ -3.68M
Cash Flow
Free Cash Flow$ -22.69M$ -5.79M$ -981.03K$ -1.57M$ -1.59M
Operating Cash Flow$ -22.59M$ -5.79M$ -981.03K$ -1.57M$ -1.59M
Investing Cash Flow$ -5.24M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 45.34M$ 6.21M$ 1.02M$ 1.62M$ 1.59M
Currency in USD

Pelthos Therapeutics Earnings and Revenue History

Pelthos Therapeutics Debt to Assets

Pelthos Therapeutics Cash Flow

Pelthos Therapeutics Forecast EPS vs Actual EPS